07/07/2026
Shortage of Medications at Public Health Facilities: The Driving Force
Analytical Perspective By: Festus Kuushomwa
Despite substantial investment in expanding health infrastructure through the construction of additional health facilities and the establishment of outreach points, overcrowding remains a persistent challenge in many health systems. This apparent paradox reflects a broader imbalance in health system priorities rather than simply a shortage of physical infrastructure. Increasing the number of facilities without addressing the underlying drivers of disease is unlikely to reduce demand for healthcare services sustainably.
A major contributing factor is the continued dominance of a curative, treatment-oriented model of care. Health systems often allocate a disproportionate share of resources to diagnosing and treating illness after it has occurred, while comparatively fewer resources are invested in disease prevention, health promotion, and addressing the social determinants of health. This approach results in an ever-growing number of patients requiring clinical management, particularly for preventable communicable diseases and the rapidly increasing burden of non-communicable diseases. Consequently, health facilities experience high patient volumes, prolonged waiting times, increased workloads for healthcare workers, and pressure on limited financial and material resources.
From a public health perspective, prevention is both more effective and more cost-efficient than treatment. Evidence consistently demonstrates that investments in immunisation, health education, sanitation, nutrition, early disease detection, vector control, to***co control, physical activity promotion, and community-based preventive interventions substantially reduce disease incidence and healthcare utilisation. Strong primary healthcare systems that prioritise prevention reduce avoidable hospital admissions and improve population health outcomes while enhancing health system resilience.
The recurrent shortages of medicines observed in many health systems are also closely linked to the predominance of curative care. As increasing numbers of patients require long-term treatment for conditions that could have been prevented or detected earlier, demand for pharmaceuticals rises substantially. This places considerable strain on procurement systems, supply chains, and health budgets. Medicine stock-outs therefore reflect not only supply chain inefficiencies but also the cumulative consequences of a disease burden that exceeds the capacity of the health system to respond sustainably.
A prevention-oriented health system would fundamentally alter this trajectory. By reducing the incidence of preventable diseases, fewer individuals would require expensive clinical interventions, thereby decreasing demand for medicines, diagnostic services, and hospital admissions. Resources currently consumed by treatment could be redirected towards strengthening community health programmes, preventive services, health promotion initiatives, and broader investments in primary healthcare. Such a reorientation aligns with the principles of sustainable health systems, universal health coverage, and the preventive vision articulated in the World Health Organisation framework on primary healthcare.
However, prevention should not be viewed as an alternative to curative services but rather as the foundation upon which effective health systems are built. High-performing health systems maintain an appropriate balance between health promotion, disease prevention, early diagnosis, treatment, rehabilitation, and palliative care. Countries that achieve better health outcomes typically invest heavily in community-based prevention while ensuring equitable access to quality clinical services when needed.
Therefore, the persistent overcrowding of health facilities is less a consequence of insufficient infrastructure than of an imbalance in health system investment. Expanding facilities without simultaneously strengthening prevention and health promotion merely increases the system's capacity to treat disease rather than reducing the occurrence of disease itself. A strategic shift towards preventive and promotive healthcare would lower disease incidence, reduce medicine consumption, improve health system efficiency, decrease healthcare expenditure, and ultimately contribute to more equitable and sustainable population health outcomes.